Transaction Advisory

Carve-out

Deals designed with your business in mind

Over the last 10 years, our collaborative teams have closed more than 120 transactions—each one tailored to meet the needs and objectives of the company.

As your partner, we’ll deliver the same highly specialized and adaptive methodology to identify non-strategic assets and help you get the most out of your divestments.

Why choose Alira Health?

With Alira Health as your partner, you will benefit from:

  • Access to our in-house clinical, regulatory, and market access experts to capture the full value of assets
  • A global team delivering a full spectrum of services
  • Proven methodology tailored to each client’s needs

Related news

M&A
Publications August 3, 2021
What You Should Know Before Choosing a Healthcare Transaction Advisory Firm
What’s most important when selecting a firm for your next transaction? Global experience, staff profiles, technical expertise? To learn more read our latest TAD Infographic.
M&A MedTech Pharma
News April 12, 2021
Alira Health Strengthens its Growth Strategy with a $35M Funding, led by Creadev
Alira Health strengthens its growth strategy with a $35M funding, led by Creadev.
M&A Pharma
News December 20, 2020
We Announce our role as Strategic Advisor to Mérieux Equity Partners and Mérieux Participations 3 for Entering the Capital of CTRS
We are pleased to announce our role as strategic advisor to Mérieux Equity Partners as they join the Series A financing round of Cell-Easy, through Mérieux’s newly established venture fund, OMX.
M&A
News November 29, 2020
We Announce our Role as Strategic Advisor to Benvic in the Acquisition of Luc & Bel
We are proud to announce our role as strategic advisor to Benvic in the acquisition of Luc & Bel.
M&A
Publications November 1, 2020
Five Key Success Factors for Managing Transactions in Full Virtual Mode
It is no secret that the COVID-19 pandemic has presented new challenges for businesses, and virtual has become the ‘new normal’, including for transactions.
M&A MedTech
Publications October 10, 2020
Q3 2020 Medical Device Contract Development and Manufacturing M&A Report
Despite the COVID-19 pandemic, M&A activity in the global CDMO industry has been exceptionally strong in 2020 with a record number of transactions completed during the third quarter alone.
M&A
News September 11, 2020
We Announce our Role as Advisor to Sagard NewGen
We are pleased to announce our role as Advisor to Sagard NewGen for the equity investment in Laboratoires Delbert. This recent capital raise of €40m supports the company’s growth(...)

Our locations around the globe

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.